NGM·Healthcare·$1.1B·#215 / 520 in Healthcare
TNDM Tandem Diabetes Care, Inc.
51SPECULATIVE
CATEGORY BREAKDOWN
GROWTH13
QUALITY51
STABILITY67
VALUATION100
GOVERNANCE36
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+7.9%
13
> 50% strong
Gross Margin
Revenue retained after direct costs
53.8%
76
> 50% strong
Cash Runway
Months of cash at current burn rate
112 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
286.4%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.0x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
-9
14
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.0%
8
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.5%
91
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE TNDM WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when TNDM's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.